Marvin Fields, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 3700 South St, Lakewood, CA 90712 Phone: 562-531-2550 |
Dr. Robert H Mckay, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3700 South St, Lakewood, CA 90712 Phone: 562-602-6810 |
Chin Seung, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 3700 South St, Lakewood, CA 90712 Phone: 562-531-2550 |
Mark Schein, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3700 South St, Lakewood, CA 90712 Phone: 562-602-6810 Fax: 562-630-3594 |
Anand Lapsi, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3700 South St, Lakewood, CA 90712 Phone: 562-602-6810 |
Robert Gottlieb, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 3700 South St, Lakewood, CA 90712 Phone: 562-531-2500 |
News Archive
Research conducted by Massachusetts Eye and Ear Infirmary (MEEI) Cornea Service Director and Harvard Medical School Professor Reza Dana, M.D., M. Sc., MPH, and colleagues at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.
In a study of children with cystic fibrosis, French researchers found evidence of very early onset defective bone mineralization in the lumbar spine that was not caused by either nutritional status or lung disease.
Predicting outcomes for cancer patients based on tumor-immune system interactions is an emerging clinical approach, and new research from Wake Forest Baptist Medical Center is advancing the field when it comes to the most deadly types of breast cancer.
In a kind of molecular gymnastics, scientists at the University of North Carolina at Chapel Hill School of Medicine have devised a gene therapy cocktail that has the potential to treat some inherited diseases associated with "misfolded" proteins.
Agilent Technologies Inc. today introduced Agilent SurePrint G3 Gene Expression Microarrays, providing up to one million features per standard 1-by-3-inch slide for added throughput, unique coverage which includes both coding and non-coding RNA, and cost effectiveness.
› Verified 2 days ago